Provided by Tiger Trade Technology Pte. Ltd.

GraniteShares YieldBoost HIMS ETF

5.51
-0.0349-0.63%
Post-market: 5.510.00000.00%18:43 EDT
Volume:6K
Turnover:31.61K
Market Cap:551.01K
PE:- -
High:5.61
Open:5.57
Low:5.51
Close:5.54
52wk High:25.79
52wk Low:5.51
Shares:100.00K
Float Shares:100.00K
Volume Ratio:0.88
T/O Rate:5.72%
Dividend:8.49
Dividend Rate:154.01%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

BUZZ-BofA says Hims & Hers 2026 revenue target hinges on GLP-1 growth, lowers PT

Reuters
·
May 26

Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 26

BofA Adjusts Price Target on Hims & Hers Health to $25 From $28

MT Newswires Live
·
May 26

Hims & Hers : Bofa Global Research Cuts Price Objective to $25.00 From $28.00

THOMSON REUTERS
·
May 26

Does Medicine's New Obsession Really Work? -- Barron's

Dow Jones
·
May 23

Hims & Hers Health Is Maintained at Hold by Truist Securities

Dow Jones
·
May 22

Truist Adjusts Price Target on Hims & Hers Health to $23 From $18, Maintains Hold Rating

MT Newswires Live
·
May 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)

TIPRANKS
·
May 22

YieldMax HIMS ETF Declares Weekly Dividend of $0.2186 Per Share

Deep News
·
May 22

Moderately bullish activity in Hims and Hers Health with shares up 3.78%

TIPRANKS
·
May 22

Sector Update: Healthcare Stocks Rise Thursday Afternoon

MT Newswires Live
·
May 22

Hims & Hers Health to Sell Generic GLP-1 Drugs in Canada

Dow Jones
·
May 21

Hims & Hers launches generic semaglutide access in Canada from CAD 149/month

Reuters
·
May 21

Hims & Hers: Introduces Access to Generic Semaglutide for Canadian Customers

THOMSON REUTERS
·
May 21

CORRECTED-Hims offers Apotex's generic semaglutide in Canada after Novo patent expiry

Reuters
·
May 21

Hims & Hers: IF Prescribed by a Licensed Healthcare Provider, Personalized Treatment Plans Start at C$149/Mo

THOMSON REUTERS
·
May 21

Live Longer and Better. Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 21

Analysts’ Top Healthcare Picks: Hims & Hers Health (HIMS), SAB Biotherapeutics (SABS)

TIPRANKS
·
May 20

Hims CFO Oluyemi Okupe sells 7,950 shares for $187,914.74

Reuters
·
May 20

Hims & Hers Health Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 20